Prosecution Insights
Last updated: October 25, 2026

United Arab Emirates University

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 56 patents granted in the last 365 days

Analysis

United Arab Emirates University has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed among 3 examiners and 3 art units, showing separate examination assignments across the pending docket.

WILSON, JERICA KATLYNN is the busiest examiner, with 1 pending matter. The identical examiner-level count indicates that no single examiner carries more of the pending activity in the supplied data. Counsel should therefore manage the matters individually and account for the separate art-unit assignments.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
3
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (67%)
1
Medium (33%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (33%)
§103 only1 (33%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
67% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WILSON, JERICA KATLYNN 1 60.5% +39.8%
MACCAGNO, PIERRE L 1 24.3% +30.8%
HOFFPAUIR, ANDREW ELI 1 40.6% +50.8%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18732158 Home Based Portable Piezoelectric Detection Device And System HOFFPAUIR, ANDREW ELI 8d
18766050 SYSTEM AND METHOD FOR DIAGNOSTICS AND FINDING TREATMENTS FOR MILD COGNITIVE IMPAIRMENT, DEMENTIAS AND NEURODEGENERATIVE DISEASES MACCAGNO, PIERRE L —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18732158 Home Based Portable Piezoelectric Detection Device And System HOFFPAUIR, ANDREW ELI 8d
18925790 NEW USE OF RECA INHIBITOR AND DERIVATIVE COMPOUNDS FOR CANCER TREATMENT WILSON, JERICA KATLYNN —
18766050 SYSTEM AND METHOD FOR DIAGNOSTICS AND FINDING TREATMENTS FOR MILD COGNITIVE IMPAIRMENT, DEMENTIAS AND NEURODEGENERATIVE DISEASES MACCAGNO, PIERRE L —

Top Art Units

Art UnitApps
1621 1
3687 1
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18925790 NEW USE OF RECA INHIBITOR AND DERIVATIVE COMPOUNDS FOR CANCER TREATMENT WILSON, JERICA KATLYNN 1621 §103 Non-Final OA — Pending Oct 24, 2024
18766050 SYSTEM AND METHOD FOR DIAGNOSTICS AND FINDING TREATMENTS FOR MILD COGNITIVE IMPAIRMENT, DEMENTIAS AND NEURODEGENERATIVE DISEASES MACCAGNO, PIERRE L 3687 §101 Non-Final OA — Pending Jul 08, 2024
18732158 Home Based Portable Piezoelectric Detection Device And System HOFFPAUIR, ANDREW ELI 3791 §103§112 Non-Final OA 8d Pending Jun 03, 2024

Managing United Arab Emirates University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does United Arab Emirates University have?

United Arab Emirates University has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most United Arab Emirates University applications?

Jerica Katlynn Wilson has the most, with 1 of United Arab Emirates University's pending office actions.

What technology area are United Arab Emirates University's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month